- Home
- BBIO vs TME Comparison
BBIO vs TME Comparison
Compare BBIO & TME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | TME |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | China |
| Employees | N/A | 5690 |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 15.1B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBIO | TME |
|---|---|---|
| Price | $74.46 | $8.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 8 |
| Target Price | ★ $86.33 | $19.44 |
| AVG Volume (30 Days) | 2.7M | ★ 10.6M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $10.73 |
| Revenue Next Year | $73.78 | $10.19 |
| P/E Ratio | ★ N/A | $15.69 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $42.09 | $7.94 |
| 52 Week High | $84.94 | $26.70 |
Technical Indicators
Market Signals| Indicator | BBIO | TME |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 37.99 |
| Support Level | $70.65 | N/A |
| Resistance Level | $79.57 | $9.80 |
| Average True Range (ATR) | 2.38 | 0.27 |
| MACD | 0.78 | -0.04 |
| Stochastic Oscillator | 97.98 | 29.19 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About TME Tencent Music Entertainment Group each representing two
Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.